Aker BioMarine AS (OSL:AKBM)
Norway
· Delayed Price · Currency is NOK 66.70
+1.80 (2.77%)
Feb 21, 2025, 4:25 PM CET
Aker BioMarine AS Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Operating Revenue | 198.9 | 335.3 | 277.2 | 262.1 | 288.59 | Upgrade
|
| Revenue | 198.9 | 335.3 | 277.2 | 262.1 | 288.59 | Upgrade
|
| Revenue Growth (YoY) | -40.68% | 20.96% | 5.76% | -9.18% | 17.23% | Upgrade
|
| Cost of Revenue | 129.9 | 222.4 | 162.4 | 174 | 176.03 | Upgrade
|
| Gross Profit | 69 | 112.9 | 114.8 | 88.1 | 112.56 | Upgrade
|
| Selling, General & Admin | 61 | 90.5 | 86.5 | 84.3 | 86.85 | Upgrade
|
| Other Operating Expenses | -2 | -4 | -4.4 | -2.7 | -0.09 | Upgrade
|
| Operating Expenses | 75.6 | 107.1 | 98.5 | 95 | 103.84 | Upgrade
|
| Operating Income | -6.6 | 5.8 | 16.3 | -6.9 | 8.72 | Upgrade
|
| Interest Expense | -8 | -33.4 | -20.3 | -13.7 | -18.74 | Upgrade
|
| Interest & Investment Income | - | 2.4 | 0.6 | - | 0.88 | Upgrade
|
| Earnings From Equity Investments | - | -3 | - | - | - | Upgrade
|
| Currency Exchange Gain (Loss) | - | -2.6 | 8.1 | 0.6 | -0.28 | Upgrade
|
| Other Non Operating Income (Expenses) | 0.4 | -2.7 | -1.7 | -1.7 | 11.83 | Upgrade
|
| EBT Excluding Unusual Items | -14.2 | -33.5 | 3 | -21.7 | 2.41 | Upgrade
|
| Gain (Loss) on Sale of Assets | - | - | - | 0.4 | 1.31 | Upgrade
|
| Asset Writedown | - | -0.5 | - | -5.8 | -0.04 | Upgrade
|
| Other Unusual Items | - | - | 9.2 | 19.7 | -2.98 | Upgrade
|
| Pretax Income | -14.2 | -34 | 12.2 | -7.4 | 0.69 | Upgrade
|
| Income Tax Expense | 0.1 | -25 | 2.2 | 0.6 | 6.15 | Upgrade
|
| Earnings From Continuing Operations | -14.3 | -9 | 10 | -8 | -5.46 | Upgrade
|
| Earnings From Discontinued Operations | 195.8 | - | - | - | - | Upgrade
|
| Net Income | 181.5 | -9 | 10 | -8 | -5.46 | Upgrade
|
| Net Income to Common | 181.5 | -9 | 10 | -8 | -5.46 | Upgrade
|
| Shares Outstanding (Basic) | - | 88 | 88 | 88 | 78 | Upgrade
|
| Shares Outstanding (Diluted) | - | 88 | 88 | 88 | 78 | Upgrade
|
| Shares Change (YoY) | - | 0.04% | 0.05% | 12.20% | 13.05% | Upgrade
|
| EPS (Basic) | - | -0.10 | 0.11 | -0.09 | -0.07 | Upgrade
|
| EPS (Diluted) | - | -0.10 | 0.11 | -0.09 | -0.07 | Upgrade
|
| Free Cash Flow | -8.2 | 1.5 | -25.4 | -76.1 | -72.7 | Upgrade
|
| Free Cash Flow Per Share | - | 0.02 | -0.29 | -0.87 | -0.93 | Upgrade
|
| Gross Margin | 34.69% | 33.67% | 41.41% | 33.61% | 39.00% | Upgrade
|
| Operating Margin | -3.32% | 1.73% | 5.88% | -2.63% | 3.02% | Upgrade
|
| Profit Margin | 91.25% | -2.68% | 3.61% | -3.05% | -1.89% | Upgrade
|
| Free Cash Flow Margin | -4.12% | 0.45% | -9.16% | -29.03% | -25.19% | Upgrade
|
| EBITDA | 38.3 | 49.9 | 61.1 | 38.5 | 49.75 | Upgrade
|
| EBITDA Margin | 19.26% | 14.88% | 22.04% | 14.69% | 17.24% | Upgrade
|
| D&A For EBITDA | 44.9 | 44.1 | 44.8 | 45.4 | 41.03 | Upgrade
|
| EBIT | -6.6 | 5.8 | 16.3 | -6.9 | 8.72 | Upgrade
|
| EBIT Margin | -3.32% | 1.73% | 5.88% | -2.63% | 3.02% | Upgrade
|
| Effective Tax Rate | - | - | 18.03% | - | 894.04% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.